Mali

in page functions
[French]
Total population (2016) 18,134,830
Birth cohort (2016) 769,782
Surviving Infants (surviving to 1 year per year, 2016) 712,324
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 75/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 115/1000
World Bank Index, IDA (2012) 3.64
Co-financing status (2016) Initial self-financing
No. of districts/territories (2014) 63

Gavi support for Mali

Type of support

Approvals

2001-2020 (US$)
(30 Apr 2016)

Commitments

2001-2020 (US$)
(30 Apr 2016)

Disbursements

2000-2016 (US$)
(30 Apr 2016)

% Disbursed

(30 Apr 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Cash Support (CASHSUPP) $160,000 $185,000 $160,000 100%
Health system strengthening (HSS 1) $4,575,800 $4,575,800 $4,575,800 100%
Health system strengthening (HSS 2) $8,640,000 $20,160,000 $8,640,000 100%
HepB mono (NVS) $1,689,699 $1,689,699 $1,689,699 100%
HPV Demo (NVS) $348,139 $348,139 $348,613 100%
Immunisation services support (ISS) $5,004,607 $5,004,607 $5,004,607 100%
Injection safety support (INS) $666,222 $666,222 $666,222 100%
IPV (NVS) $1,314,518 $2,154,018 $810,003 62%
Meningitis A (NVS) $274,000 $274,000
Meningitis A - mini catch-up campaign (NVS) $2,725,500 $2,725,500
Meningitis A - mini catch-up op.costs (OPC) $2,175,637 $2,175,637
Penta (NVS) $45,345,215 $45,345,215 $44,128,399 97%
Pneumo (NVS) $66,104,982 $66,104,982 $70,167,683 106%
Rotavirus (NVS) $13,724,742 $13,724,742 $11,219,400 82%
Vaccine Introduction Grant (VIG) $2,137,381 $2,137,381 $1,479,000 69%
Yellow Fever (NVS) $6,137,962 $6,137,962 $6,402,906 104%
Total $161,024,404 $173,408,904 $155,292,332

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Mali DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 81%
M:F sex ratio at birth (2016) 1.05
Household survey: DTP3 coverage for male (2011) 63.30%
Household survey: DTP3 coverage for female (2011) 62.80%
Household survey: Last DTP3 survey (2011) 63%
% districts achieving > 80% DTP3 coverage (2014) 89%
% districts achieving < 50% DTP3 coverage (2014) 5%
MCV WHO/UNICEF estimates (2014) 80%

Breakdown of support

Non-vaccine support Vaccine support
13% 87%
$20,525,628 $134,766,699

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Mali

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

09 February 2016

animation

New data confirms immunisation as a best buy in public health

Johns Hopkins University study shows 16-fold return on investment in immunisation from 2011 to 2020

07 February 2016

Africa United

Seth Berkley helps kick-off Africa United universal immunisation campaign

Gavi CEO attends final of 2016 African Nations football championship to support launch of ‘Every Shot Counts’.

close icon

modal window here